
A Multicenter, Open-Label, Phase 1b Study of Carfilzomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CHAMPION-2)
Keywords: مولتیپل میلوما; Carfilzomib; Clinical trial; Multiple myeloma; Newly diagnosed; Proteasome inhibitor;